Von Hippel–Lindau disease (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Von Hippel–Lindau disease" in English language version.

refsWebsite

Global rank English rank

25nih.gov

4^th place

17doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

4web.archive.org

1^st place

2clevelandclinic.org

4,925^th place

3,597^th place

1orpha.net

3,537^th place

7,177^th place

1inserm.fr

9,568^th place

low place

1archive.today

14^th place

1ama-assn.org

3,257^th place

3,398^th place

1oup.com

485^th place

440^th place

1yalemedicine.org

low place

1aao.org

low place

7,618^th place

1sps.nhs.uk

low place

1raps.org

low place

1businesswire.com

615^th place

407^th place

1cancernetwork.com

low place

1zenodo.org

621^st place

380^th place

1msn.com

117^th place

145^th place

1apnews.com

129^th place

89^th place

1rarediseases.org

5,181^st place

3,260^th place

aao.org

Moshfeghi, Darius (October 29, 2013). "Laser Photocoagulation and Photodynamic Therapy for Von Hippel-Lindau Retinal Capillary Hemangiomas". American Academy of Ophthalmology.

ama-assn.org

archopht.ama-assn.org

Wong WT; Agrón E; Coleman HR; et al. (February 2007). "Genotype–phenotype correlation in von Hippel–Lindau disease with retinal angiomatosis". Archives of Ophthalmology. 125 (2): 239–45. doi:10.1001/archopht.125.2.239. PMC 3019103. PMID 17296901. Archived from the original on 2008-12-12. Retrieved 2008-10-22.

apnews.com

Marchione, Marilynn; Breed, Allen G., The Hatfield-McCoy feud can in part be explained by a rare medical condition that causes rage, Associated Press (AP), August 4, 2023

archive.today

Wong WT; Agrón E; Coleman HR; et al. (February 2007). "Genotype–phenotype correlation in von Hippel–Lindau disease with retinal angiomatosis". Archives of Ophthalmology. 125 (2): 239–45. doi:10.1001/archopht.125.2.239. PMC 3019103. PMID 17296901. Archived from the original on 2008-12-12. Retrieved 2008-10-22.

businesswire.com

"Merck Receives Priority Review From FDA for New Drug Application for HIF-2α Inhibitor Belzutifan (MK-6482)" (Press release). Merck. 16 March 2016. Retrieved 25 April 2021 – via Business Wire.

cancernetwork.com

"FDA Grants Priority Review to Belzutifan for von Hippel-Lindau Disease–Associated RCC". Cancer Network. 16 March 2021. Retrieved 2021-04-26.

clevelandclinic.org

my.clevelandclinic.org

Clinic, Cleveland (2017-10-16). "Von Hippel-Lindau Disease (VHL)". Cleveland Clinic.
Clinic, Cleveland (October 2024). "Hemangioblastoma". Cleveland Clinic.

doi.org

Leung RS, Biswas SV, Duncan M, Rankin S (2008). "Imaging features of von Hippel-Lindau disease". Radiographics. 28 (1): 65–79, quiz 323. doi:10.1148/rg.281075052. PMID 18203931.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Richard, S; Gardie, B; Couvé, S; Gad, S (May 30, 2012). "Von Hippel-Lindau: How a rare disease illuminates cancer biology". Seminars in Cancer Biology. 23 (1): 26–37. doi:10.1016/j.semcancer.2012.05.005. PMID 22659535. Archived from the original (PDF) on April 9, 2022. Retrieved April 20, 2018.
Wong WT; Agrón E; Coleman HR; et al. (February 2007). "Genotype–phenotype correlation in von Hippel–Lindau disease with retinal angiomatosis". Archives of Ophthalmology. 125 (2): 239–45. doi:10.1001/archopht.125.2.239. PMC 3019103. PMID 17296901. Archived from the original on 2008-12-12. Retrieved 2008-10-22.
Maher ER; Glenn GM; Walther M; et al. (June 2011). "von Hippel-Lindau disease: a clinical and scientific review". European Journal of Human Genetics. 19 (6): 617–23. doi:10.1038/ejhg.2010.175. PMC 3110036. PMID 21386872.
Friedrich, CA (December 1, 1999). "Von Hippel-Lindau syndrome. A pleomorphic condition". Cancer. 86 (11 Suppl): 2478–82. doi:10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5. PMID 10630173. S2CID 45672391.
Kondo, K; Kaelin Jr, WG (10 March 2001). "The von Hippel–Lindau Tumor Suppressor Gene". Experimental Cell Research. 264 (1): 117–125. doi:10.1006/excr.2000.5139. PMID 11237528.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; et al. (May 2010). "Genetic analysis of von Hippel-Lindau disease". Hum. Mutat. 31 (5): 521–37. doi:10.1002/humu.21219. PMID 20151405. S2CID 38910112.
Knudson, AG (Nov 2001). "Two genetic hits (more or less) to cancer". Nature Reviews Cancer. 1 (2): 157–62. doi:10.1038/35101031. PMID 11905807. S2CID 20201610.
Kaelin, WG (2007). "Von Hippel-Lindau disease". Annual Review of Pathology. 2: 145–73. doi:10.1146/annurev.pathol.2.010506.092049. PMID 18039096.
Bader, HL; Hsu, T (June 4, 2012). "Systemic VHL gene functions and the VHL disease". FEBS Letters. 586 (11): 1562–9. doi:10.1016/j.febslet.2012.04.032. PMC 3372859. PMID 22673568.
Kumar, P. S.; Venkatesh, K.; Srikanth, L.; Sarma, P. V.; Reddy, A. R.; Subramanian, S.; Phaneendra, B. V. (July 2013). "Novel three missense mutations observed in Von Hippel-Lindau gene in a patient reported with renal cell carcinoma". Indian Journal of Human Genetics. 19 (3): 373–376. doi:10.4103/0971-6866.120809. PMC 3841571. PMID 24339559.
Lonser RR (June 2003). "von Hippel-Lindau disease". Lancet. 361 (9374): 2059–67. doi:10.1016/S0140-6736(03)13643-4. PMID 12814730. S2CID 13783714.
Shuin, Yamasaki, Tamura, Okuda, Furihata, Ashida, Taro, Ichiro, Kenji, Heiwa, Mutsuo, Shingo (June 2006). "Von Hippel–Lindau Disease: Molecular Pathological Basis, Clinical Criteria, Genetic Testing, Clinical Features of Tumors and Treatment". Japanese Journal of Clinical Oncology. 36 (6): 337–343. doi:10.1093/jjco/hyl052. PMID 16818478.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Priesemann M; Davies KM; Perry LA; et al. (2006). "Benefits of screening in von Hippel-Lindau disease – comparison of morbidity associated with initial tumours in affected parents and children". Horm. Res. 66 (1): 1–5. doi:10.1159/000093008. PMID 16651847. S2CID 29862078.
Kim, JJ; Rini, BI; Hansel, DE (2010). "Von Hippel Lindau Syndrome". Diseases of DNA Repair. Advances in Experimental Medicine and Biology. Vol. 685. pp. 228–49. doi:10.1007/978-1-4419-6448-9_22. ISBN 978-1-4419-6447-2. PMID 20687511.
Von Hippel E (1904). "Ueber eine sehr seltene Erkrankung der Netzhaut". Albrecht von Graefe's Archiv für Ophthalmologie. 59: 83–106. doi:10.1007/bf01994821. S2CID 22425158.
Lindau A (1927). "Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation". Acta Ophthalmologica. 4 (1–2): 193–226. doi:10.1111/j.1755-3768.1926.tb07786.x. S2CID 73385451.

inserm.fr

hal.inserm.fr

Richard, S; Gardie, B; Couvé, S; Gad, S (May 30, 2012). "Von Hippel-Lindau: How a rare disease illuminates cancer biology". Seminars in Cancer Biology. 23 (1): 26–37. doi:10.1016/j.semcancer.2012.05.005. PMID 22659535. Archived from the original (PDF) on April 9, 2022. Retrieved April 20, 2018.

msn.com

msnbc.msn.com

"Hatfield–McCoy feud blamed on 'rage' disease". MSNBC.com. 2007-04-05. Archived from the original on 2007-04-07. Retrieved 2007-04-05.

nih.gov

pubmed.ncbi.nlm.nih.gov

Leung RS, Biswas SV, Duncan M, Rankin S (2008). "Imaging features of von Hippel-Lindau disease". Radiographics. 28 (1): 65–79, quiz 323. doi:10.1148/rg.281075052. PMID 18203931.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Richard, S; Gardie, B; Couvé, S; Gad, S (May 30, 2012). "Von Hippel-Lindau: How a rare disease illuminates cancer biology". Seminars in Cancer Biology. 23 (1): 26–37. doi:10.1016/j.semcancer.2012.05.005. PMID 22659535. Archived from the original (PDF) on April 9, 2022. Retrieved April 20, 2018.
Wong WT; Agrón E; Coleman HR; et al. (February 2007). "Genotype–phenotype correlation in von Hippel–Lindau disease with retinal angiomatosis". Archives of Ophthalmology. 125 (2): 239–45. doi:10.1001/archopht.125.2.239. PMC 3019103. PMID 17296901. Archived from the original on 2008-12-12. Retrieved 2008-10-22.
Frantzen, Carlijn; Links, Thera P.; Giles, Rachel H. (21 June 2012). "Von Hippel-Lindau Syndrome". Von Hippel-Lindau Disease. University of Washington, Seattle. PMID 20301636. Retrieved 30 March 2013. {{cite book}}: |work= ignored (help)
Maher ER; Glenn GM; Walther M; et al. (June 2011). "von Hippel-Lindau disease: a clinical and scientific review". European Journal of Human Genetics. 19 (6): 617–23. doi:10.1038/ejhg.2010.175. PMC 3110036. PMID 21386872.
Friedrich, CA (December 1, 1999). "Von Hippel-Lindau syndrome. A pleomorphic condition". Cancer. 86 (11 Suppl): 2478–82. doi:10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5. PMID 10630173. S2CID 45672391.
Kondo, K; Kaelin Jr, WG (10 March 2001). "The von Hippel–Lindau Tumor Suppressor Gene". Experimental Cell Research. 264 (1): 117–125. doi:10.1006/excr.2000.5139. PMID 11237528.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; et al. (May 2010). "Genetic analysis of von Hippel-Lindau disease". Hum. Mutat. 31 (5): 521–37. doi:10.1002/humu.21219. PMID 20151405. S2CID 38910112.
Knudson, AG (Nov 2001). "Two genetic hits (more or less) to cancer". Nature Reviews Cancer. 1 (2): 157–62. doi:10.1038/35101031. PMID 11905807. S2CID 20201610.
Kaelin, WG (2007). "Von Hippel-Lindau disease". Annual Review of Pathology. 2: 145–73. doi:10.1146/annurev.pathol.2.010506.092049. PMID 18039096.
Bader, HL; Hsu, T (June 4, 2012). "Systemic VHL gene functions and the VHL disease". FEBS Letters. 586 (11): 1562–9. doi:10.1016/j.febslet.2012.04.032. PMC 3372859. PMID 22673568.
Kumar, P. S.; Venkatesh, K.; Srikanth, L.; Sarma, P. V.; Reddy, A. R.; Subramanian, S.; Phaneendra, B. V. (July 2013). "Novel three missense mutations observed in Von Hippel-Lindau gene in a patient reported with renal cell carcinoma". Indian Journal of Human Genetics. 19 (3): 373–376. doi:10.4103/0971-6866.120809. PMC 3841571. PMID 24339559.
Lonser RR (June 2003). "von Hippel-Lindau disease". Lancet. 361 (9374): 2059–67. doi:10.1016/S0140-6736(03)13643-4. PMID 12814730. S2CID 13783714.
Mikhail, Magui (January 30, 2023). "Von Hippel-Lindau Syndrome". National Library of Medicine. PMID 29083737.
Shuin, Yamasaki, Tamura, Okuda, Furihata, Ashida, Taro, Ichiro, Kenji, Heiwa, Mutsuo, Shingo (June 2006). "Von Hippel–Lindau Disease: Molecular Pathological Basis, Clinical Criteria, Genetic Testing, Clinical Features of Tumors and Treatment". Japanese Journal of Clinical Oncology. 36 (6): 337–343. doi:10.1093/jjco/hyl052. PMID 16818478.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Priesemann M; Davies KM; Perry LA; et al. (2006). "Benefits of screening in von Hippel-Lindau disease – comparison of morbidity associated with initial tumours in affected parents and children". Horm. Res. 66 (1): 1–5. doi:10.1159/000093008. PMID 16651847. S2CID 29862078.
Kim, JJ; Rini, BI; Hansel, DE (2010). "Von Hippel Lindau Syndrome". Diseases of DNA Repair. Advances in Experimental Medicine and Biology. Vol. 685. pp. 228–49. doi:10.1007/978-1-4419-6448-9_22. ISBN 978-1-4419-6447-2. PMID 20687511.

ncbi.nlm.nih.gov

Wong WT; Agrón E; Coleman HR; et al. (February 2007). "Genotype–phenotype correlation in von Hippel–Lindau disease with retinal angiomatosis". Archives of Ophthalmology. 125 (2): 239–45. doi:10.1001/archopht.125.2.239. PMC 3019103. PMID 17296901. Archived from the original on 2008-12-12. Retrieved 2008-10-22.
Frantzen, Carlijn; Links, Thera P.; Giles, Rachel H. (21 June 2012). "Von Hippel-Lindau Syndrome". Von Hippel-Lindau Disease. University of Washington, Seattle. PMID 20301636. Retrieved 30 March 2013. {{cite book}}: |work= ignored (help)
Maher ER; Glenn GM; Walther M; et al. (June 2011). "von Hippel-Lindau disease: a clinical and scientific review". European Journal of Human Genetics. 19 (6): 617–23. doi:10.1038/ejhg.2010.175. PMC 3110036. PMID 21386872.
Bader, HL; Hsu, T (June 4, 2012). "Systemic VHL gene functions and the VHL disease". FEBS Letters. 586 (11): 1562–9. doi:10.1016/j.febslet.2012.04.032. PMC 3372859. PMID 22673568.
Kumar, P. S.; Venkatesh, K.; Srikanth, L.; Sarma, P. V.; Reddy, A. R.; Subramanian, S.; Phaneendra, B. V. (July 2013). "Novel three missense mutations observed in Von Hippel-Lindau gene in a patient reported with renal cell carcinoma". Indian Journal of Human Genetics. 19 (3): 373–376. doi:10.4103/0971-6866.120809. PMC 3841571. PMID 24339559.
Mikhail, Magui (January 30, 2023). "Von Hippel-Lindau Syndrome". National Library of Medicine. PMID 29083737.

rarediseases.info.nih.gov

"Von Hippel-Lindau disease | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2018-04-17.

meshb.nlm.nih.gov

"von Hippel-Lindau Disease". Medical Subject Headings (MeSH). U.S. National Library of Medicine. Retrieved 4 April 2022.

orpha.net

RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Von Hippel Lindau disease". www.orpha.net. Retrieved 25 May 2019.{{cite web}}: CS1 maint: numeric names: authors list (link)

oup.com

academic.oup.com

Shuin, Yamasaki, Tamura, Okuda, Furihata, Ashida, Taro, Ichiro, Kenji, Heiwa, Mutsuo, Shingo (June 2006). "Von Hippel–Lindau Disease: Molecular Pathological Basis, Clinical Criteria, Genetic Testing, Clinical Features of Tumors and Treatment". Japanese Journal of Clinical Oncology. 36 (6): 337–343. doi:10.1093/jjco/hyl052. PMID 16818478.{{cite journal}}: CS1 maint: multiple names: authors list (link)

raps.org

"MHRA awards first 'innovation passport' under new pathway". RAPS (Press release). Retrieved 25 April 2021.

rarediseases.org

"Von Hippel-Lindau Disease". Rare Disease Database. National Organization for Rare Disorders. 2019. Archived from the original on 25 April 2015. Retrieved 4 April 2022.

semanticscholar.org

api.semanticscholar.org

Friedrich, CA (December 1, 1999). "Von Hippel-Lindau syndrome. A pleomorphic condition". Cancer. 86 (11 Suppl): 2478–82. doi:10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5. PMID 10630173. S2CID 45672391.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; et al. (May 2010). "Genetic analysis of von Hippel-Lindau disease". Hum. Mutat. 31 (5): 521–37. doi:10.1002/humu.21219. PMID 20151405. S2CID 38910112.
Knudson, AG (Nov 2001). "Two genetic hits (more or less) to cancer". Nature Reviews Cancer. 1 (2): 157–62. doi:10.1038/35101031. PMID 11905807. S2CID 20201610.
Lonser RR (June 2003). "von Hippel-Lindau disease". Lancet. 361 (9374): 2059–67. doi:10.1016/S0140-6736(03)13643-4. PMID 12814730. S2CID 13783714.
Priesemann M; Davies KM; Perry LA; et al. (2006). "Benefits of screening in von Hippel-Lindau disease – comparison of morbidity associated with initial tumours in affected parents and children". Horm. Res. 66 (1): 1–5. doi:10.1159/000093008. PMID 16651847. S2CID 29862078.
Von Hippel E (1904). "Ueber eine sehr seltene Erkrankung der Netzhaut". Albrecht von Graefe's Archiv für Ophthalmologie. 59: 83–106. doi:10.1007/bf01994821. S2CID 22425158.
Lindau A (1927). "Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation". Acta Ophthalmologica. 4 (1–2): 193–226. doi:10.1111/j.1755-3768.1926.tb07786.x. S2CID 73385451.

sps.nhs.uk

"Belzutifan". SPS - Specialist Pharmacy Service. 18 March 2021. Archived from the original on 26 April 2021. Retrieved 25 April 2021.

web.archive.org

Richard, S; Gardie, B; Couvé, S; Gad, S (May 30, 2012). "Von Hippel-Lindau: How a rare disease illuminates cancer biology". Seminars in Cancer Biology. 23 (1): 26–37. doi:10.1016/j.semcancer.2012.05.005. PMID 22659535. Archived from the original (PDF) on April 9, 2022. Retrieved April 20, 2018.
"Belzutifan". SPS - Specialist Pharmacy Service. 18 March 2021. Archived from the original on 26 April 2021. Retrieved 25 April 2021.
"Hatfield–McCoy feud blamed on 'rage' disease". MSNBC.com. 2007-04-05. Archived from the original on 2007-04-07. Retrieved 2007-04-05.
"Von Hippel-Lindau Disease". Rare Disease Database. National Organization for Rare Disorders. 2019. Archived from the original on 25 April 2015. Retrieved 4 April 2022.

yalemedicine.org

Yale, Medicine (October 2024). "What is a pheochromocytoma". Yale Medicine.

zenodo.org

Von Hippel E (1904). "Ueber eine sehr seltene Erkrankung der Netzhaut". Albrecht von Graefe's Archiv für Ophthalmologie. 59: 83–106. doi:10.1007/bf01994821. S2CID 22425158.